BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus. [electronic resource]
Producer: 20121105Description: 595-602 p. digitalISSN:- 1521-6551
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- B-Cell Activating Factor -- antagonists & inhibitors
- Chemistry, Pharmaceutical -- methods
- Clinical Trials, Phase III as Topic
- Drug Approval
- Drug Design
- European Union
- Humans
- Lupus Erythematosus, Systemic -- drug therapy
- Mice
- Recombinant Fusion Proteins -- therapeutic use
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.